| Vighnesh Walavalkar, MD | |
|
9500 Gilman Dr, La Jolla, CA 92093-5004 | |
| (858) 534-0455 | |
| Not Available |
| Full Name | Vighnesh Walavalkar |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 17 Years |
| Location | 9500 Gilman Dr, La Jolla, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215201983 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | A118337 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ucsf Medical Center | San francisco, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of California San Francisco | 4486567229 | 1298 |
News Archive
The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.
Generic versions of a class of medicines called "biologics" would not be significantly cheaper than brand-name versions of the medicines, according to research from professors at Duke University's Fuqua School of Business.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Four University of California, Davis, researchers have been given $50,000 each in the inaugural year of a competitive grant program aimed at facilitating the conversion of technology generated from university research into commercial applications.
In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.
› Verified 1 days ago
| Entity Name | University Of California Sfgh Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154396208 PECOS PAC ID: 5496668410 Enrollment ID: O20031113000632 |
News Archive
The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.
Generic versions of a class of medicines called "biologics" would not be significantly cheaper than brand-name versions of the medicines, according to research from professors at Duke University's Fuqua School of Business.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Four University of California, Davis, researchers have been given $50,000 each in the inaugural year of a competitive grant program aimed at facilitating the conversion of technology generated from university research into commercial applications.
In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.
› Verified 1 days ago
| Entity Name | University Of California San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.
Generic versions of a class of medicines called "biologics" would not be significantly cheaper than brand-name versions of the medicines, according to research from professors at Duke University's Fuqua School of Business.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Four University of California, Davis, researchers have been given $50,000 each in the inaugural year of a competitive grant program aimed at facilitating the conversion of technology generated from university research into commercial applications.
In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.
› Verified 1 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740382993 PECOS PAC ID: 3577476761 Enrollment ID: O20040430001354 |
News Archive
The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.
Generic versions of a class of medicines called "biologics" would not be significantly cheaper than brand-name versions of the medicines, according to research from professors at Duke University's Fuqua School of Business.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Four University of California, Davis, researchers have been given $50,000 each in the inaugural year of a competitive grant program aimed at facilitating the conversion of technology generated from university research into commercial applications.
In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.
› Verified 1 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.
Generic versions of a class of medicines called "biologics" would not be significantly cheaper than brand-name versions of the medicines, according to research from professors at Duke University's Fuqua School of Business.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Four University of California, Davis, researchers have been given $50,000 each in the inaugural year of a competitive grant program aimed at facilitating the conversion of technology generated from university research into commercial applications.
In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vighnesh Walavalkar, MD 18503 Linda Cir, Cerritos, CA 90703-6355 Ph: () - | Vighnesh Walavalkar, MD 9500 Gilman Dr, La Jolla, CA 92093-5004 Ph: (858) 534-0455 |
News Archive
The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.
Generic versions of a class of medicines called "biologics" would not be significantly cheaper than brand-name versions of the medicines, according to research from professors at Duke University's Fuqua School of Business.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Four University of California, Davis, researchers have been given $50,000 each in the inaugural year of a competitive grant program aimed at facilitating the conversion of technology generated from university research into commercial applications.
In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.
› Verified 1 days ago
Ashley Lynette Cardenas, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 9444 Medical Center Dr, La Jolla, CA 92037 Phone: 619-414-8429 | |
Dr. Julie B. Steele, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8605 | |
Miriam Bloch, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5580 La Jolla Blvd, Pmb 610, La Jolla, CA 92037 Phone: 858-729-0993 Fax: 858-729-0992 | |
Dr. Ann C Rearden, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 9300 Campus Point Drive, Mc 0612, La Jolla, CA 92037 Phone: 858-657-6595 Fax: 858-657-6045 | |
Dr. Frank W. Hall, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8605 | |
Dr. Robert W. Sharpe, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8605 | |
Dr. Keith Edward Thompson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd # 211c, La Jolla, CA 92037 Phone: 858-554-8605 |